Frontlight ResearchEarly access
Trial site
Azienda Ospedaliera - Universitaria di Parma
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Mesothelioma2 trials
- Childhood cancers1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Liver and biliary tract cancer1 trial
- Neuroendocrine tumours1 trial
- Sarcoma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 33 trials
- Phase 21 trial
- Status
- Recruiting3 trials
- Completed2 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica3 trials
- Istituto Oncologico Veneto IRCCS2 trials
- Italian Sarcoma Group1 trial
- Manuel Monreal1 trial
- TransThera Sciences (Nanjing), Inc.1 trial
Running trials
Recruiting
Active, not recruiting
Recruiting
Recruiting
Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
Recruiting
Recruiting
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Childhood cancers1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Mesothelioma1 recruiting
- Neuroendocrine tumours1 recruiting
- Sarcoma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026